News
Attorneys for Planned Parenthood argue that cutting Medicaid payments to their abortion providers will harm vulnerable ...
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback